Company Overview - China Hengjia Leasing Group Co., Ltd. is a limited liability exempt company registered in the Cayman Islands, listed on the Hong Kong Stock Exchange since 2002 under stock code 00379. The company operates in the trade of medical, health, and personal hygiene products, manufacturing and selling health foods and nutritional supplements, as well as property and financial investments [2]. Financial Performance - As of June 30, 2025, the company reported total operating revenue of HKD 36.36 million, a year-on-year decrease of 15.2%. The net profit attributable to shareholders was -HKD 34.34 million, an increase of 13.62% year-on-year. The gross profit margin stood at 18.3%, and the debt-to-asset ratio was 13.07% [1][3]. Stock Performance - On August 25, the Hang Seng Index rose by 1.94%, closing at 25,829.91 points. Hengjia Leasing's stock closed at HKD 0.09 per share, up 21.62%, with a trading volume of 800,000 shares and a turnover of HKD 72,600. The stock experienced a volatility of 31.08%. Over the past month, the stock has seen a cumulative decline of 2.63%, while year-to-date, it has increased by 124.24%, outperforming the Hang Seng Index by 26.32% [1]. Valuation Metrics - Currently, there are no institutional investment ratings for Hengjia Leasing. The average price-to-earnings (P/E) ratio for the other financial industry is 16.65 times, with a median of -0.19 times. Hengjia Leasing's P/E ratio is -1.67 times, ranking 151st in the industry. Comparatively, other companies in the sector have P/E ratios of 2.62 times (China Merchants China Fund), 3.03 times (Weixin Jinkou), 4.04 times (Hong Kong Credit), 4.42 times (Guoyin Financial Leasing), and 4.56 times (Qifu Technology) [1].